TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6297841

Group type: EXPERIMENTAL
Intervention: Activated charcoal, 50 gm
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ammonium chloride
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Alkalinization of urine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acidification of urine
Number of subjects: 6
Study: 30682843

Group type: EXPERIMENTAL
Intervention: Low Carbohydrate High Fat (LCHF) diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: High Carbohydrate (HCHO) diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Periodised Carbohydrate (PCHO) diet
Number of subjects: 0
Study: 30962603

Group type: EXPERIMENTAL
Intervention: Personalized information treatments targeting parents' misbeliefs about their children's absences
Number of subjects: 28080

Group type: COMPARATOR
Intervention: Control group (no additional information)
Number of subjects: 28080
Study: 27089808

Group type: EXPERIMENTAL
Intervention: LEXICAL (representing the output of the lexical phonology)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: DEEP (an experimental orthography representing the input of the lexical phonology)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: PHONEMIC (representing a level between the output of the lexical phonology and the output of the post‐lexical phonology)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study: 23592025

Group type: COMPARATOR
Intervention: Tranexamic acid (TNA) 10 mg/kg administered intravenously 20 min before tourniquet deflation and repeated 3 h after surgery for unilateral TKA; an additional dose of TNA 10 mg/kg before tourniquet deflation for the second TKA in bilateral TKA patients.
Number of subjects: 326
Study: 22275464

Group type: EXPERIMENTAL
Intervention: GaitMaster gait rehabilitation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (non-intervention phase)
Number of subjects: 12
Study: 19184351

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthrinse (CHX)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 50
Study: 17216337

Group type: EXPERIMENTAL
Intervention: Aqua‐E (water-soluble vitamin E formulation)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oil‐based softgels (control)
Number of subjects: 8
Study: 16452103

Group type: EXPERIMENTAL
Intervention: Sham device (validated sham acupuncture needle)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Sham device
Number of subjects: 270
Study: 14675055

Group type: EXPERIMENTAL
Intervention: Candesartan 16 mg orally for 10 days during LBNP
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10797163

Group type: EXPERIMENTAL
Intervention: Follow-up home visits by a physician (INT1-HVP)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Instructions by a physiotherapist in their home (INT2-PI)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Standard aftercare (controls)
Number of subjects: 155
Study: 8970145

Group type: EXPERIMENTAL
Intervention: 120% VO2peak
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 6 W.kg‐1
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100% VO2peak + 10% PAS
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100% VO2peak + 20% MAS
Number of subjects: 10
Study: 1450093

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 3912093

Group type: EXPERIMENTAL
Intervention: Intravenous PGE1 (15 micrograms/h for 72 h)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 16
Study: 31676660

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Group Therapy (CRGT) - combining mindfulness-based stress reduction with brain training activities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mutual Aid Group Therapy (active control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions (CRGT and Mutual Aid Group Therapy)
Number of subjects: 0
Study: 26797106

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g and tramadol 1 mg/kg (group 1T)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Paracetamol 1 g and tramadol 1.5 mg/kg (group 1.5T)
Number of subjects: 94
Study: 25844849

Group type: EXPERIMENTAL
Intervention: Increases in maternal education
Number of subjects: 1624

Group type: COMPARATOR
Intervention: Control group (mothers did not increase education)
Number of subjects: 1624
Study: 23911336

Group type: EXPERIMENTAL
Intervention: Third tertile of dairy intake (≥2.2 servings/day)
Number of subjects: 1456

Group type: COMPARATOR
Intervention: First tertile of dairy intake (≤1.5 servings/day)
Number of subjects: 1456
Study: 21352613

Group type: EXPERIMENTAL
Intervention: Advance care planning discussions with an independent mediator (maximum three sessions)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Trial participation
Number of subjects: 77
Study: 19702638

Group type: EXPERIMENTAL
Intervention: School-based environmental and educational intervention promoting water consumption
Number of subjects: 17
Study: 17904748

Group type: EXPERIMENTAL
Intervention: ReCell system
Number of subjects: 82

Group type: COMPARATOR
Intervention: Classic skin grafting
Number of subjects: 82
Study: 15515192

Group type: EXPERIMENTAL
Intervention: Urokinase (UK) instillation (100,000 IU in 150 ml normal saline daily)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (anti-tuberculous agents only)
Number of subjects: 43
Study: 11584199

Group type: EXPERIMENTAL
Intervention: Complete autonomic nerve‐preserving surgery without lateral node dissection (D1)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Surgery with dissection of the lateral lymph nodes including autonomic nerves (D2) followed by oral administration of carmofur for one year
Number of subjects: 51
Study: 9040712

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 8200466

Group type: EXPERIMENTAL
Intervention: Balloon catheter with extra-amniotic saline infusion (BCEAS)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Prostaglandin E2 (PGE2) vaginal pessaries
Number of subjects: 109
Study: 3316312

Group type: EXPERIMENTAL
Intervention: Alprazolam (ALP)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Alprazolam + Desipramine (ALP-DMI)
Number of subjects: 79
Study: 31355939

Group type: EXPERIMENTAL
Intervention: modified figure-of-eight (mFoE) suture
Number of subjects: 150

Group type: COMPARATOR
Intervention: standard figure-of-eight (sFoE) suture
Number of subjects: 150
Study: 28666993

Group type: EXPERIMENTAL
Intervention: Digoxin use in patients without HF (20% of 8,981 patients)
Number of subjects: 21105

Group type: EXPERIMENTAL
Intervention: Digoxin use in patients with HF (37% of 12,124 patients)
Number of subjects: 21105
Study: 26955702

Group type: EXPERIMENTAL
Intervention: Hemofiltration combined with hemoabsorption
Number of subjects: 60
Study: 23743017

Group type: EXPERIMENTAL
Intervention: Dialysate sodium concentration 135 mmol/L
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dialysate sodium concentration 145 mmol/L
Number of subjects: 10
Study: 22059307

Group type: EXPERIMENTAL
Intervention: Weekly 75-minute play program throughout the school year
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 86
Study: 18272271

Group type: EXPERIMENTAL
Intervention: Ginger 1g/day for 4 days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Vitamin B6 40 mg/day for 4 days
Number of subjects: 70
Study: 16982276

Group type: EXPERIMENTAL
Intervention: MTAD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NaOCl/MTAD
Number of subjects: 0

Group type: COMPARATOR
Intervention: NaOCl (positive control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Autoclaved dentin disks (negative control)
Number of subjects: 0
Study: 14999162

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 118
Study: 12488233

Group type: EXPERIMENTAL
Intervention: Oroenteral diets (oral drinks or duodenal infusions of complex formula)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intravenous feeding
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Elemental formula (duodenal infusion)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 27
Study: 10773013

Group type: EXPERIMENTAL
Intervention: 0.25 mg of triazolam
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 mg of zolpidem
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8650464

Group type: EXPERIMENTAL
Intervention: Clonidine (mean = 0.5 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 1617042

Group type: EXPERIMENTAL
Intervention: Cefprozil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 0
Study: 3158125

Group type: EXPERIMENTAL
Intervention: Nifedipine (40 mg, long‐acting preparation)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combination of Nifedipine and Acebutolol
Number of subjects: 35
Study: 30882644

Group type: EXPERIMENTAL
Intervention: Virtual reality immersive training with computerized cognitive therapy (experimental group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Computerized cognitive therapy (control group)
Number of subjects: 42
Study: 29107496

Group type: EXPERIMENTAL
Intervention: Active robotic total hip arthroplasty (THA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional manual technique
Number of subjects: 0
Study: 26678427

Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol (IPA) group
Number of subjects: 95

Group type: COMPARATOR
Intervention: Chlorhexidine gluconate (CHG) group
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study: 24727841

Group type: EXPERIMENTAL
Intervention: Rituximab (1 g at weeks 0 and 2)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 120
Study: 22543117

Group type: EXPERIMENTAL
Intervention: loose (125)I seeds with automated seed delivery system and real‐time intraoperative planning
Number of subjects: 495
Study: 20571129

Group type: EXPERIMENTAL
Intervention: Low magnitude, high frequency mechanical stimulation (active treatment)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 174
Study: 18612883

Group type: EXPERIMENTAL
Intervention: Bupropion (BUPRO, 300 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 40
Study: 16336425

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bare stents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 0
Study: 12242194

Group type: EXPERIMENTAL
Intervention: Educational course (Group 1)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Printed educational material (Group 2)
Number of subjects: 64
Study: 10094124

Group type: EXPERIMENTAL
Intervention: Functional neuroimaging data
Number of subjects: 0
Study: 7594332

Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of 30 mg twice daily of lansoprazole
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous drip infusion of 30 mg twice daily of lansoprazole
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of 60 mg once daily of lansoprazole
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intravenous bolus injection (30 mg twice daily) vs intravenous bolus injection (60 mg once daily)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intravenous bolus injection vs intravenous drip infusion
Number of subjects: 10
Study: 2302074

Group type: EXPERIMENTAL
Intervention: Lactate (LA) bath (Na, 138; K, 1.5; Ca, 1.75; Mg, 0.75; Cl, 109.5; AC, 17.5; and D,L‐lactate, 17.5 mmol/L)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Acetate (AC) bath (35 mmol/L)
Number of subjects: 14
Study: 6448552

Group type: EXPERIMENTAL
Intervention: Sufentanil (0.7 microgram/kg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fentanyl (7 microgram/kg)
Number of subjects: 15
Study: 31106697

Group type: COMPARATOR
Intervention: Bilingual word recognition in white noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilingual word learning in noise or quiet
Number of subjects: 0
Study: 31220935

Group type: COMPARATOR
Intervention: Ambient temperature at 20°C
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Ambient temperature at 22°C
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Ambient temperature at 24°C
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Ambient temperature at 26°C
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Ambient temperature at 28°C
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Ambient temperature at 30°C
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Ambient temperature increase
Number of subjects: 216
Study: 27767328

Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate and Vilanterol (FF/VI; 100 μg and 25 μg respectively)
Number of subjects: 16485

Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate and Vilanterol (FF/VI)
Number of subjects: 16485

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16485
Study: 25263076

Group type: EXPERIMENTAL
Intervention: OperaVOX
Number of subjects: 100
Study: 22788726

Group type: EXPERIMENTAL
Intervention: Seal with pit and fissure sealant on localized marginal defects (group A: n=43)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Total restoration replacement (group B: n=40)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Untreated restorations (group C: n=43)
Number of subjects: 32
Study: 21220024

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 19751080

Group type: EXPERIMENTAL
Intervention: experimenter-provided implementation intention
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: self-generated implementation intention
Number of subjects: 248

Group type: COMPARATOR
Intervention: questionnaire plus planning instruction
Number of subjects: 248

Group type: COMPARATOR
Intervention: questionnaire-only
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: self-generated implementation intention (moderated by compliance)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: experimenter-provided implementation intention (comparison with self-generated)
Number of subjects: 248
Study: 16925790

Group type: EXPERIMENTAL
Intervention: Apotransferrin (dosage regimens not specified)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Apotransferrin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (10 consecutive patients)
Number of subjects: 20
Study: 15324535

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 49
Study: 11255425

Group type: EXPERIMENTAL
Intervention: Ipriflavone, 200 mg 3 times per day (n = 234)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Placebo (n = 240)
Number of subjects: 474
Study: 9663729

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isosorbide‐5‐mononitrate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol + Isosorbide‐5‐mononitrate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7811986

Group type: EXPERIMENTAL
Intervention: One-day program (n = 39)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Six-week course (n = 14)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Both programs
Number of subjects: 53
Study: 3078419

Group type: EXPERIMENTAL
Intervention: Antegrade Bretschneider cardioplegia
Number of subjects: 19

Group type: COMPARATOR
Intervention: Retrograde cardioplegia
Number of subjects: 19
Study: 8373842

Group type: EXPERIMENTAL
Intervention: Natural estrogens conjugated with progesterone (Group II)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Triphasic oral contraceptives (Group III)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (Group I)
Number of subjects: 47
Study: 356618

Group type: EXPERIMENTAL
Intervention: Direct bonding with small filler particle adhesive
Number of subjects: 42

Group type: COMPARATOR
Intervention: Indirect bonding with larger filler particle adhesive
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Mesh-backed brackets
Number of subjects: 42

Group type: COMPARATOR
Intervention: Perforated brackets
Number of subjects: 42
Study: 31856838

Group type: EXPERIMENTAL
Intervention: AZD8848 60 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27764529

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 4000 IU/d for 3 months
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 39
Study: 26160083

Group type: EXPERIMENTAL
Intervention: Single intra-operative injection of triamcinolone (0.5-1cc of triamcinolone 40mg/cc)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Intra-operative and two post-operative injections of triamcinolone (0.5-1cc of triamcinolone 40mg/cc)
Number of subjects: 70
Study: 22999893

Group type: EXPERIMENTAL
Intervention: Ziprasidone 120mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ziprasidone 80mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ziprasidone 160mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21070333

Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.1% hydrocortisone butyrate
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (healthy adults)
Number of subjects: 21
Study: 19107656

Group type: EXPERIMENTAL
Intervention: Direct individual therapy
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Indirect individual therapy
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Direct group therapy
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Indirect group therapy
Number of subjects: 161

Group type: COMPARATOR
Intervention: Usual therapy control group
Number of subjects: 161
Study: 17306417

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (75 U/axilla)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (50 U/axilla)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study: 14609313

Group type: EXPERIMENTAL
Intervention: Ethane levels in breath of ADHD patients
Number of subjects: 10

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Butane levels in breath of ADHD patients
Number of subjects: 10

Group type: COMPARATOR
Intervention: Butane levels in breath of healthy volunteers
Number of subjects: 10
Study: 10890292

Group type: EXPERIMENTAL
Intervention: Skills intervention
Number of subjects: 1396

Group type: EXPERIMENTAL
Intervention: Community intervention
Number of subjects: 1396

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 1396
Study: 8982417

Group type: EXPERIMENTAL
Intervention: n-docosanol 10% cream (early treatment)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: n-docosanol 10% cream (late treatment)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 1607535

Group type: EXPERIMENTAL
Intervention: Heparin (intravenous)
Number of subjects: 0
Study: 6374644

Group type: EXPERIMENTAL
Intervention: Wire mesh element within the 'buzzer and pad' enuresis alarm device
Number of subjects: 0

Group type: COMPARATOR
Intervention: No wire mesh element
Number of subjects: 0
Study: 31112062

Group type: EXPERIMENTAL
Intervention: Modified Woman's Condom (WC2)
Number of subjects: 287

Group type: COMPARATOR
Intervention: FC2 female condom
Number of subjects: 287
Study: 28686657

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) and probenecid
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 26015075

Group type: EXPERIMENTAL
Intervention: Tai Chi sessions (8 sessions, one-on-one for group A, online for group B)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Tai Chi (group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard care (group B)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Tai Chi (both groups)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Qualitative assessment (focus groups at 9 months)
Number of subjects: 72
Study: 23628378

Group type: COMPARATOR
Intervention: Transcutaneous electric nerve stimulation (TENS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intra‐articular hyaluronic acid (HA)
Number of subjects: 50
Study: 21318190

Group type: EXPERIMENTAL
Intervention: Imaginal desensitization plus motivational interviewing (IDMI)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Gamblers Anonymous (GA) referral
Number of subjects: 68
Study: 19588640

Group type: EXPERIMENTAL
Intervention: Topical AzA 15% gel and oral doxycycline (100 mg), both twice daily for ≤ 12 weeks
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Topical AzA 15% gel
Number of subjects: 172

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 172

Group type: COMPARATOR
Intervention: Both AzA gel and vehicle
Number of subjects: 172
Study: 17129610

Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Methadone (METH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy subjects (CONT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Heroin-dependent patients (HDP)
Number of subjects: 30
Study: 14706014

Group type: EXPERIMENTAL
Intervention: estramustine phosphate (560 mg/day) plus LHRH agonist
Number of subjects: 57

Group type: COMPARATOR
Intervention: flutamide (375 mg/day) plus LHRH agonist
Number of subjects: 57
Study: 11751195

Group type: EXPERIMENTAL
Intervention: Bronchoscopy simulator training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional training methods
Number of subjects: 28